Mitul Mehta

Assistant Clinical Professor, Ophthalmology
School of Medicine

M.D., University of Southern California, 2008


M.S., Georgetown University, 2004, Physiology & Biophysics

Phone: (949) 824-6256
Fax: (949) 824-4015
Email: mcmehta@uci.edu

University of California, Irvine

Gavin Herbert Eye Institute
850 Health Sciences Road
Mail Code: 4375
Irvine, CA 92697

picture of Mitul  Mehta

Research
Interests
Surgical Devices, Surgical Techniques, Retinal Detachments, Diabetic Retinopathy, Age-Related Macular Degeneration (AMD), Epiretinal Membranes, Macular Holes, Uveitis, Radiation Retinopathy
   
Academic
Distinctions
Board Certified in Ophthalmology
   
Research
Abstract
Mitul Mehta MD MS, is a board-certified ophthalmologist with fellowship training in medical and surgical diseases of the retina. He sees patients at the UCI Medical Center in Orange, CA and the Gavin Herbert Eye Institute in Irvine, CA.
A Southern California native, Dr. Mehta graduated from the Massachusetts Institute of Technology (MIT), he then completed a Master of Science degree in Physiology & Biophysics at Georgetown University and earned his MD degree from the University of Southern California (USC). After completing his ophthalmology residency at the University of Cincinnati, he graduated from fellowship training in vitreoretinal surgery at the New York Eye & Ear Infirmary of Mount Sinai.
In addition to the care of patients with vitreoretinal disorders, Dr. Mehta teaches medical students, residents, and fellows, and does research in surgical devices, techniques and vitreoretinal diseases such as diabetic retinopathy and macular degeneration.
   
Publications Shah C, Gentile RA, Mehta MC. Perfluorocarbon Liquids Ability to Protect the Macula from Intraocular Dropping of Metallic Foreign Bodies: A Model Eye Study. RETINA. The Journal of Retinal and Vitreous Diseases. Retina. 2016 Jan 16. [Epub ahead of print]
   
  Shah C; Schroeder B; Mehta M. Perfluorocarbon-Balanced Salt Solution Interface Deflects Intraocular Foreign Bodies. Investigative Ophthalmology & Visual Science June 2015, Vol.56(7), 5104. doi:
   
  Mehta MC, Finger PT. Angled transscleral intravitreal injection: a crossover study. Eur J Ophthalmol. 2015 Mar-Apr;25(2):173-6. doi: 10.5301/EJO.2014.12778. Epub 2014 Nov 10. PMID:25384968.
   
Grants Mehta M, sub-investigator: A Phase II, Randomized, Single-Masked, Sham-Controlled Study of the Safety, Tolerability and Evidence of Activity of Intravitreal APL-2 Therapy in Patients with Geographic Atrophy (GA)
   
Mehta M, sub-investigator: A Two-Year, Randomized, Double-Masked, Multicenter, Three-Arm Study Comparing the Efficacy and Safety of RTH258 versus Aflibercept in Subjects with Neovascular Age-Related Macular Degeneration (RTH258-C001)
   
Mehta M, sub-investigator: A PHASE RANDOMIZED, DOUBLE-MASKED, PLACEBO-CONTROLLED MULTICENTER CLINICAL TRIAL DESIGNED TO EVALUATE THE SAFETY AND EXPLORATORY EFFICACY OF LUMINATE® (ALG-1001) IN INDUCING PVD IN SUBJECTS WITH NON-PROLIFERATIVE DIABETIC RETINOPATHY
   
Mehta M, sub-investigator: A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE-MASKED, SHAM-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF LAMPALIZUMAB ADMINISTERED INTRAVITREALLY TO PATIENTS WITH GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION
   
Mehta M, sub-investigator:A Multi-Center, Two-Stage, Open-Label Phase 1 and Randomized, Active Controlled, Masked Phase II Study to Evaluate the Safety and Efficacy of Intravitreal Implantation of NT-503-3 Encapsulated Cell Technology Compared with Eylea® for the Treatment of Recurrent Subfoveal Choroidal Neovascualarization (CNV) Secondary to Age-Related Macular Degeneration (AMD)
   
Mehta M, sub-investigator: MA PHASE 3 RANDOMIZED, DOUBLE-MASKED, CONTROLLED TRIAL TO ESTABLISH THE SAFETY AND EFFICACY OF INTRAVITREOUS ADMINISTRATION OF FOVISTATM (ANTI PDGF-B PEGYLATED APTAMER) ADMINISTERED IN COMBINATION WITH EITHER AVASTIN® OR EYLEA® COMPARED TO AVASTIN® OR EYLEA® MONOTHERAPY IN SUBJECTS WITH SUBFOVEAL NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
   
Mehta M, sub-investigator: A PHASE 2, DOUBLE-MASKED, RANDOMIZED, DOUBLE-MASKED, CONTROLLED, MULTIPLE-DOSE, REGIMEN-RANGING STUDY OF THE EFFICACY AND SAFETY OF INTRAVITREAL REGN2176-3 IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
   
Mehta M, sub-investigator: A Phase 2, Multicenter, Randomized Double Masked, Placebo Controlled, Parallel Group Study to Investigate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharacodynamics of GSK933776 in Adult Patients with Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration
   
Professional
Societies
American Academy of Ophthalmology (AAO)
American Society of Retina Specialists (ASRS)
American Association of Physicians of Indian origin (AAPI)
   
Other Experience Fellowship in Vitreoretinal Surgery and Diseases
New York Eye & Ear Infirmary of Mount Sinai

Research Center Gavin Herbert Eye Institute
   
   
Link to this profile http://www.faculty.uci.edu/profile.cfm?faculty_id=6081
   
Last updated 08/12/2016